These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8175006)

  • 1. DNA ploidy in epithelial ovarian cancer: a new independent prognostic factor?
    Tropé C; Kaern J
    Gynecol Oncol; 1994 Apr; 53(1):1-4. PubMed ID: 8175006
    [No Abstract]   [Full Text] [Related]  

  • 2. [DNA ploidy in epithelial ovarian cancer--an independent prognostic factor].
    Tropé CG; Abeler V; Baekelandt M; Kaern J
    Tidsskr Nor Laegeforen; 2000 Jan; 120(1):43-9. PubMed ID: 10815478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA ploidy as a prognostic factor in patients with ovarian carcinoma.
    Pietrzak K; Olszewski W
    Pol J Pathol; 1998; 49(3):141-4. PubMed ID: 9810171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-ploidy as an independent prognostic factor in patients with serous ovarian carcinoma.
    But I; Gorisek B
    Int J Gynaecol Obstet; 2000 Dec; 71(3):259-62. PubMed ID: 11102619
    [No Abstract]   [Full Text] [Related]  

  • 6. [The clinical value of DNA ploidy in ovarian cancer].
    Obrebowska A; Spaczyński M
    Ginekol Pol; 1997 Oct; 68(10):478-82. PubMed ID: 9780508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [DNA ploidy and results of first line chemotherapy in ovarian cancer patients].
    Milczek T; Klasa-Mazurkiewicz D; Emerich J; Debniak J
    Ginekol Pol; 2006 Aug; 77(8):589-96. PubMed ID: 17076189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of deoxyribonucleic acid ploidy and S-phase fraction as prognostic parameters in advanced epithelial ovarian carcinoma: a prospective study.
    Kaern J; Tropé CG; Kristensen GB; Tveit KM; Pettersen EO
    Am J Obstet Gynecol; 1994 Feb; 170(2):479-87. PubMed ID: 8116701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA flow cytometry as a new prognostic factor in ovarian malignancies. A review.
    Tropé C; Makar A; Kaern J
    Acta Obstet Gynecol Scand Suppl; 1992; 155():95-7. PubMed ID: 1502897
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric analysis of nuclear DNA content in patients with recurrent epithelial ovarian cancer.
    Hamaguchi K; Nishimura H; Tateno N; Yakushiji M; Yokoyama MM
    Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2836-42. PubMed ID: 2074393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy changes the DNA ploidy in ovarian cancer.
    Venesmaa P; Paavonen J; Forss M; Ylikorkala O
    Br J Obstet Gynaecol; 1995 Jul; 102(7):568-9. PubMed ID: 7647063
    [No Abstract]   [Full Text] [Related]  

  • 13. [DNA examinations in gynecological cancer and breast cancer].
    Tropé C; Kaern J; Pettersen EO; Iversen OE
    Tidsskr Nor Laegeforen; 1991 May; 111(13):1638-42. PubMed ID: 2063365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA ploidy analysis of borderline epithelial ovarian tumours.
    Lodhi S; Najam S; Pervez S
    J Pak Med Assoc; 2000 Oct; 50(10):349-51. PubMed ID: 11109755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS; Gersell DJ; Yim S
    Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and biological factors in the pathogenesis of ovarian cancer.
    Berek JS; Martínez-Maza O; Hamilton T; Tropé C; Kaern J; Baak J; Rustin GJ
    Ann Oncol; 1993; 4 Suppl 4():3-16. PubMed ID: 8312207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian carcinoma heterogeneity as demonstrated by DNA ploidy.
    Zangwill BC; Balsara G; Dunton C; Varello M; Rebane BA; Hernandez E; Atkinson BF
    Cancer; 1993 Apr; 71(7):2261-7. PubMed ID: 8453547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Properties of cancer cell DNA affects the prognosis].
    Kildal W; Pradhan M; Cyll K; Jacobsen JE; Kristensen GB; Danielsen HE
    Tidsskr Nor Laegeforen; 2017 Oct; 137(19):. PubMed ID: 29043733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic and clinical value of morphometry and DNA cytometry in borderline ovarian tumors: a prospective study.
    Verbruggen MB; van Diest PJ; Baak JP; Broeckaert MA; Kenemans P; Verheijen RH
    Int J Gynecol Pathol; 2009 Jan; 28(1):35-40. PubMed ID: 19047910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic variables, operative characteristics, and DNA ploidy in predicting outcome in ovarian epithelial carcinoma.
    Rice LW; Mark SD; Berkowitz RS; Goff BA; Lage JM
    Obstet Gynecol; 1995 Sep; 86(3):379-85. PubMed ID: 7651646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.